Contact: Jeff Ezell
Director, Communications and Public Relations
(201) 847-5533
Email: jeff_ezell@bd.com

San Jose, CA  -- Friday, June 29, 2007 -- 

BD Biosciences, a segment of BD (Becton, Dickinson and Company), today announced the introduction of BD FACSDivaâ?¢ 6.0 software. This automated package will help scientists attain the best performance and most consistent data from BD flow cytometry systems used for important basic and clinical research.

â??BDâ??s advanced flow cytometry systems are the foundation for key medical research that requires the measurement and charting of cell characteristics and properties,â?? said Bill Rhodes, President, Cell Analysis, BD Biosciences. â??BD FACSDiva software is the most complete flow cytometer standardization system ever devised. Researchers and clinicians are no longer limited in the design and performance of high-level, multi-color experiments by the complexity of their flow cytometer setup. This new software, with our new BDâ?¢ Cytometer Setup and Tracking beads, delivers efficiencies, ease of use, and consistent, reproducible results with decreased downtime â?? all of which are essential to modern research and clinical laboratories.â??

BD FACSDiva 6.0 software includes BDâ?¢ Cytometer Setup and Tracking capability. This set of features characterizes and automates setup of the BD FACSCantoâ?¢, new BD FACSCantoâ?¢ II, BDâ?¢ LSR II, and BD FACSAriaâ?¢ flow cytometry systems. Its benefits include:

• Providing consistent, reproducible data every day
• Simplifying design of multi-color experiments
• Yielding higher quality data from multi-color experiments
• Identifying cytometer performance issues promptly

About BD

BD, a leading global medical technology company that manufactures and sells medical devices, instruments and reagents, is dedicated to improving peopleâ??s health throughout the world. BD is focused on improving drug therapy, enhancing the quality and speed of diagnosing infectious diseases, and advancing research and discovery of new drugs and vaccines. The Companyâ??s capabilities are instrumental in combating many of the worldâ??s most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs approximately 27,000 people in approximately 50 countries throughout the world. The Company serves healthcare institutions, life science researchers, clinical laboratories, industry and the general public. For more information, please visit, www.bd.com.

***